Hologic, Inc.
NASDAQ Global Select•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.Company Description
- CEO
- Mr. Stephen P. MacMillan
- Full Time Employees
- 7,063
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 250 Campus Drive Marlborough MA United States of America 01752
- IPO Date
- Mar 1, 1990
- CIK
- 0000859737
- Website
- hologic.com
- Similar Companies
- Business
- Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.
Company News
Hologic (HOLX) Suffers a Larger Drop Than the General Market: Key Insights
Hologic's Margin Stability Amid Tariffs: What's Behind the Confidence?
Can Hologic Lean on Its Strengths in a Tough Macroeconomic Climate?
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
Hologic Climbs 13% in a Month: How Should You Play the Stock?
Hologic Navigates Breast Health Slump: Is the Growth Thesis Intact?
Hologic Joins NEST Governance Committee to Advance the Use of Real-World Data in Medical Device Evaluation
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock
Why Is Diagnostic Firm Hologic Stock Trading Higher On Tuesday?
Hologic reportedly rejects $16B go-private offer from TPG, Blackstone
Hologic rejects $16 billion take-private proposal from TPG and Blackstone, Financial Times reports
HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick?
Hologic to Present New Data at ASCO 2025 Reinforcing the Practice-Changing Role of the Breast Cancer Index® Test in Helping to Deliver More Personalized Care to Patients
Is Trending Stock Hologic, Inc. (HOLX) a Buy Now?
Hologic to Webcast Presentations at Upcoming Investor Conferences
Understanding Hologic (HOLX) Reliance on International Revenue
Tariffs Dim Hologic's 2025 Expectations: Time to Reassess the Stock?
Hologic: Soft Performance, But Cheap Enough
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
Hologic Q2 Earnings & Revenues Top, '25 EPS View Lowered, Stock Down